BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26434514)

  • 1. Significance and Determinants of Cardiac Troponin I in Patients With Obstructive Hypertrophic Cardiomyopathy.
    Zhang C; Liu R; Yuan J; Cui J; Hu F; Yang W; Zhang Y; Yang C; Qiao S
    Am J Cardiol; 2015 Dec; 116(11):1744-51. PubMed ID: 26434514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum cardiac troponin I is related to increased left ventricular wall thickness, left ventricular dysfunction, and male gender in hypertrophic cardiomyopathy.
    Kubo T; Kitaoka H; Okawa M; Yamanaka S; Hirota T; Hoshikawa E; Hayato K; Yamasaki N; Matsumura Y; Yasuda N; Sugiura T; Doi YL
    Clin Cardiol; 2010 Feb; 33(2):E1-7. PubMed ID: 20043329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac troponin I is associated with non-sustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy.
    Zhou Y; Yu M; Yuan J; Liu S; Hu F; Yang Z; Cui J; Qiao S
    Heart Vessels; 2020 Jun; 35(6):876-885. PubMed ID: 31907598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on left ventricular remodeling in non-obstructive hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene.
    Magga J; Sipola P; Vuolteenaho O; Risteli J; Jääskeläinen P; Peuhkurinen K; Kuusisto J
    Am J Cardiol; 2008 Apr; 101(8):1185-90. PubMed ID: 18394456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of troponin I efflux and troponin autoantibodies in patients with dilated cardiomyopathy.
    Miettinen KH; Eriksson S; Magga J; Tuomainen P; Kuusisto J; Vanninen EJ; Turpeinen A; Punnonen KR; Pettersson K; Peuhkurinen KJ
    J Card Fail; 2008 Aug; 14(6):481-8. PubMed ID: 18672196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Values of N-Terminal Pro-B-Type Natriuretic Peptide and Cardiac Troponin I for Myocardial Fibrosis in Hypertrophic Obstructive Cardiomyopathy.
    Zhang C; Liu R; Yuan J; Cui J; Hu F; Yang W; Zhang Y; Chen Y; Qiao S
    PLoS One; 2016; 11(1):e0146572. PubMed ID: 26765106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of highly sensitive cardiac troponin T in hypertrophic cardiomyopathy to left ventricular mass and cardiovascular risk.
    Cramer G; Bakker J; Gommans F; Brouwer M; Kurvers M; Fouraux M; Verheugt F; Kofflard M
    Am J Cardiol; 2014 Apr; 113(7):1240-5. PubMed ID: 24513467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac troponins and left ventricular hypertrophy in hemodialysis patients.
    Petrović D; Obrenović R; Stojimirović B
    Clin Lab; 2008; 54(5-6):145-52. PubMed ID: 18780659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of serum cardiac troponins T and I to predict cardiac molecular changes and cardiac damage in patients with hypertrophic cardiomyopathy.
    Okamoto R; Hirashiki A; Cheng XW; Yamada T; Shimazu S; Shinoda N; Okumura T; Takeshita K; Bando Y; Kondo T; Murohara T
    Int Heart J; 2013; 54(4):202-6. PubMed ID: 23924931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of cardiac troponin to systolic global longitudinal strain in hypertrophic cardiomyopathy.
    Agarwal A; Yousefzai R; Shetabi K; Samad F; Aggarwal S; Cho C; Bush M; Jan MF; Khandheria BK; Paterick TE; Tajik AJ
    Echocardiography; 2017 Oct; 34(10):1470-1477. PubMed ID: 28849602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis on related factors of myocardial fibrosis in patients with hypertrophic cardiomyopathy].
    Zhang Y; Wu KH; Li Q; Zhang HJ; Shang YY; Pang MJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Jan; 49(1):31-36. PubMed ID: 33429483
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlations between cardiac troponin I and nonsustained ventricular tachycardia in hypertrophic obstructive cardiomyopathy.
    Liu L; Liu S; Shen L; Tu B; Hu Z; Hu F; Zheng L; Ding L; Fan X; Yao Y
    Clin Cardiol; 2020 Oct; 43(10):1150-1159. PubMed ID: 32810305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum cardiac troponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunction.
    Löwbeer C; Gustafsson SA; Seeberger A; Bouvier F; Hulting J
    Scand J Clin Lab Invest; 2004; 64(7):667-76. PubMed ID: 15513324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marked expression of plasma brain natriuretic peptide is a special feature of hypertrophic obstructive cardiomyopathy.
    Nishigaki K; Tomita M; Kagawa K; Noda T; Minatoguchi S; Oda H; Watanabe S; Morita N; Nakao K; Fujiwara H
    J Am Coll Cardiol; 1996 Nov; 28(5):1234-42. PubMed ID: 8890821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular diastolic function assessed with cardiovascular magnetic resonance imaging and exercise capacity in patients with non-obstructive hypertrophic cardiomyopathy.
    Małek LA; Chojnowska L; Kłopotowski M; Misko J; Dabrowski M; Kuśmierczyk-Droszcz B; Maczyńska R; Piotrowicz E; Ruzyłło W
    Kardiol Pol; 2009 Jan; 67(1):1-6; discussion 7-8. PubMed ID: 19253184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and determinants of elevated high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy.
    Jenab Y; Pourjafari M; Darabi F; Boroumand MA; Zoroufian A; Jalali A
    J Cardiol; 2014 Feb; 63(2):140-4. PubMed ID: 24011925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac troponin I in cats with hypertrophic cardiomyopathy.
    Connolly DJ; Cannata J; Boswood A; Archer J; Groves EA; Neiger R
    J Feline Med Surg; 2003 Aug; 5(4):209-16. PubMed ID: 12878148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association between serum cardiac troponin I and myocardial remodeling in patients with chronic heart failure].
    Liu ZQ; Cui LQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 May; 34(5):437-9. PubMed ID: 16776961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac troponin I in feline hypertrophic cardiomyopathy.
    Herndon WE; Kittleson MD; Sanderson K; Drobatz KJ; Clifford CA; Gelzer A; Summerfield NJ; Linde A; Sleeper MM
    J Vet Intern Med; 2002; 16(5):558-64. PubMed ID: 12322706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.